FR940722-0-00035 FR940722-0-00008 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 5 Delegations of Authority and Organization AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the regulations for delegations of authority relating to disclosure of official records in order to delegate authority to certain officials within the agency for disclosure to foreign governments. EFFECTIVE DATE: July 22, 1994. FOR FURTHER INFORMATION CONTACT: Ellen R. Rawlings, Division of Management Systems and Policy (HFA&hyph;340), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4976. SUPPLEMENTARY INFORMATION: In the Federal Register of November 19, 1993 (58 FR 61598), FDA published a final rule amending the regulations in §20.89 (21 CFR 20.89), effective December 20, 1993, to provide that the Commissioner of Food and Drugs (the Commissioner) may designate any other FDA officer or employee to act on the Commissioner's behalf to authorize the nonpublic disclosure, under certain specified conditions, of confidential commercial information submitted to FDA or incorporated into agency-prepared records. This amendment permits such disclosure to foreign government officials who perform counterpart functions to FDA as part of cooperative law enforcement or regulatory efforts. The amendment also permits the disclosure of trade secret information to visiting foreign scientists under certain limited conditions. Section 5.23 Disclosure of official records (21 CFR 5.23) is being revised to add §20.89(c) to the sections already referenced in §5.23(a), and to list those officials authorized to make such disclosures. Further redelegation of the authority delegated is not authorized. Authority delegated to a position by title may be exercised by a person officially designated to serve in such position in an acting capacity or on a temporary basis. List of Subjects in 21 CFR Part 5 Authority delegations (Government agencies), Imports, Organization and functions (Government agencies). Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 5 is amended as follows: PART 5_DELEGATIONS OF AUTHORITY AND ORGANIZATION 1. The authority citation for 21 CFR part 5 continues to read as follows: Authority: 5 U.S.C. 504, 552, App. 2; 7 U.S.C. 138a, 2271; 15 U.S.C. 638, 1261&hyph;1282, 3701&hyph;3711a; secs. 2&hyph;12 of the Fair Packaging and Labeling Act (15 U.S.C. 1451&hyph;1461); 21 U.S.C. 41&hyph;50, 61&hyph;63, 141&hyph;149, 467f, 679(b), 801&hyph;886, 1031&hyph;1309; secs. 201&hyph;903 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321&hyph;394); 35 U.S.C. 156; secs. 301, 302, 303, 307, 310, 311, 351, 352, 361, 362, 1701&hyph;1706, 2101, 2125, 2127, 2128 of the Public Health Service Act (42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 264, 265, 300u&hyph;300u&hyph;5, 300aa&hyph;1, 300aa&hyph;25, 300aa&hyph;27, 300aa&hyph;28); 42 U.S.C. 1395y, 3246b, 4332, 4831(a), 10007&hyph;10008; E.O. 11490, 11921, and 12591; secs. 312, 313, 314 of the National Childhood Vaccine Injury Act of 1986, Pub. L. 99&hyph;660 (42 U.S.C. 300aa&hyph;1 note). 2. Section 5.23 is amended by revising the introductory text of paragraph (a) and by adding new paragraphs (a)(10)(i) through (a)(10)(vii) to read as follows: §5.23 Disclosure of official records. (a) The following officials are authorized to make determinations to disclose official records and information under part 20 of this chapter, except that only the officials listed in paragraph (a)(1) of this section may disclose official records and information under §§20.82 and 20.85 of this chapter, and only officials listed in paragraph (a)(10) of this section may disclose information under §20.89(c) of this chapter. * * * * * (10)(i) The Associate Commissioner for Regulatory Affairs, Deputy Associate Commissioner for Regulatory Affairs, and Director, Office of Enforcement, FDA. (ii) The Director, Deputy Director, and Associate Director for Policy Coordination and Public Affairs, Center for Biologics Evaluation and Research (CBER), and Director, Division of Congressional and Public Affairs, CBER. (iii) The Director, Deputy Directors, and Associate Director for Science and Medical Affairs, Center for Drug Evaluation and Research (CDER). (iv) The Director and Deputy Director for Regulations and Policy, Center for Devices and Radiological Health (CDRH). (v) The Director, Center for Food Safety and Applied Nutrition (CFSAN), and Deputy Director for Systems and Support, CFSAN. (vi) The Director and Deputy Director, Center for Veterinary Medicine (CVM). (vii) The Director, Deputy Director, and Associate Director for Scientific Coordination, National Center for Toxicological Research (NCTR). * * * * * Dated: July 18, 1994. Michael R. Taylor, Deputy Commissioner for Policy. [FR Doc. 94&hyph;17808 Filed 7&hyph;21&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
